Should We Protect Horses from Competition Stress with Medication?

by Jon Scaccia August 13, 2024

The Olympics have just concluded, as has one of the few times a year that the spotlight is on equestrian sports. We may laugh, but horses and riders train rigorously to reach the pinnacle of performance. However, behind the polished performances and seamless teamwork lies a question that stirs the heart of the sport: should we allow horses to be medicated (will download a .pdf) during competitions, specifically with omeprazole, to manage the physical stress they endure?

The Hidden Struggle: Equine Gastric Ulcer Syndrome (EGUS)

Horses are magnificent athletes, but just like their human counterparts, they aren’t immune to the pressures of competition. One of the most common health issues in these equine athletes is Equine Gastric Ulcer Syndrome (EGUS). This condition, as the name suggests, involves the development of painful ulcers in the horse’s stomach, often exacerbated by the stress and changes in diet and management associated with training and competition.

Imagine being asked to perform at your best while dealing with a burning sensation in your stomach. That’s what many horses endure during competition, and it’s why omeprazole, a medication that reduces stomach acid, is frequently used to manage EGUS.

But here’s the crux of the issue: different equestrian governing bodies have conflicting regulations regarding the use of omeprazole during competitions. While some allow it, others argue that using it violates the principles of fair play and could give medicated horses an undue advantage. The debate is not just about fairness in sport; it’s about the welfare of the horses themselves.

Why This Matters: More Than Just Fair Play

The ethical dilemma surrounding the use of omeprazole in competitions hinges on two opposing principles: the need to maintain a “clean” sport and the moral obligation to prevent unnecessary suffering in animals.

In sports, we value the idea of a level playing field—no athlete should have an unfair advantage due to drug use. This principle is why many equestrian bodies prohibit or heavily regulate the use of medications during competitions. However, horses aren’t like human athletes who can give informed consent. They rely on us to ensure their well-being, which brings us to the ethical question: is it fair to withhold a treatment that could prevent them from suffering?

Recent research adds weight to the argument for allowing omeprazole. Studies have shown that withholding omeprazole for more than two days before a competition can lead to the recurrence of EGUS, causing the horse significant discomfort. On the other hand, administering omeprazole up until the day of competition seems to prevent this recurrence without enhancing the horse’s performance beyond its natural capability.

Connecting the Dots: How This Affects the Horses and the Sport

Let’s break this down into something we can all relate to. Think about how you feel when you’re stressed—your stomach might churn, you could lose your appetite, or experience a gnawing pain. Now, imagine that this isn’t just pre-exam jitters but a chronic condition exacerbated every time you have to perform under pressure. This is the reality for many competitive horses.

The debate over omeprazole is about more than just the rules of the game; it’s about whether we’re willing to let these animals suffer for the sake of competition. If a simple, safe treatment is available to prevent their pain, why shouldn’t it be used?

Omeprazole doesn’t give a horse superpowers; it just helps to maintain their well-being, allowing them to compete at their natural best without the added burden of gastric ulcers. When we talk about a level playing field, shouldn’t that include ensuring all horses are healthy and free from pain?

The Bigger Picture: The Future of Equestrian Sports

This debate also taps into a broader conversation about the ethical use of animals in sports. The concept of a “social license” to operate is becoming increasingly important across all industries, including sports. This license is based on public trust and approval, which is granted only when the public believes that the activity is being conducted ethically and responsibly.

In equestrian sports, maintaining this social license means being transparent about how we treat our horses and ensuring that their welfare is prioritized. Allowing the use of omeprazole could be a step towards demonstrating that we value the health and well-being of these animals over the competitive outcomes.

However, this is not just a simple yes or no decision. The concerns about long-term use of omeprazole, potential side effects, and the broader issue of why so many horses develop EGUS in the first place also need to be addressed. This includes looking at how training and management practices contribute to stress and whether more can be done to prevent EGUS without relying solely on medication.

What’s Next? The Role of Ethical Decision-Making

The decision to allow or ban omeprazole in equestrian competitions shouldn’t be made in isolation. It should be part of a larger conversation about the ethics of how we train, manage, and compete with horses. If the goal is to ensure that our horses are healthy and happy, then perhaps we need to rethink more than just the use of a single medication.

As the equestrian community continues to debate this issue, it’s essential to consider not just the rules and regulations but the real, lived experiences of the horses themselves. We owe it to them to make decisions that reflect our best understanding of their needs and welfare.

Join the Conversation

What do you think? Should the use of omeprazole be allowed during competitions to protect horse welfare, or does it compromise the integrity of the sport? How do we balance the need for fair competition with the moral obligation to prevent suffering? Share your thoughts in the comments below.